Mike Matson Analyst PerformanceSenior Analyst at Needham & Company LLCMike Matson is a stock analyst at Needham & Company LLC in the medical sector, covering 29 publicly traded companies. Over the past year, Mike Matson has issued 87 stock ratings, including buy and hold recommendations. While full access to Mike Matson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mike Matson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings169 Last 4 YearsBuy Recommendations76.92% 130 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution169RatingsDistribution of strong buy, buy, hold, and sell ratings by Mike Matson.RatingPercentageCount Strong Buy0.0%0 ratings Buy76.9%130 ratings Hold23.1%39 ratings Sell0.0%0 ratingsOut of 169 total stock ratings issued by Mike Matson at Needham & Company LLC, the majority (76.9%) have been Buy recommendations, followed by 23.1% Hold.Best & Worst CallsBest Call0000.0%PSNLFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%INMDOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ58.6% of companies on NASDAQ17 companiesNYSE41.4% of companies on NYSE12 companiesMike Matson, an analyst at Needham & Company LLC, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical29 companies100.0%Mike Matson of Needham & Company LLC specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED INSTRUMENTS12 companies41.4%MED PRODUCTS9 companies31.0%MED/DENTAL - SUPP2 companies6.9%MEDICAL SERVICES2 companies6.9%MED - GENERIC DRG1 company3.4%MEDICAL INFO SYS1 company3.4%MED - BIOMED/GENE1 company3.4%SURGICAL & MEDICAL INSTRUMENTS1 company3.4% About Mike MatsonMike Matson joined Needham & Company in 2013 covering Medical Technologies & Diagnostics. Prior to joining Needham, Mike spent nine years covering the Medical Supplies and Devices industry for Mizuho Securities and Wells Fargo Securities. He previously worked in the medical device industry for Stryker’s Orthopaedics and Endoscopy divisions in marketing and product development. Mike has received multiple awards for stock picking and earnings estimate accuracy. He was ranked first for stock picking in the Health Care Equipment & Supplies sector in the 2017 Thomson Reuters Analyst Awards. He was also ranked tenth in the TipRanks Top Ten Analysts of 2016 (across all sectors), third for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2014 Thomson Reuters Analyst Awards, first for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2013 Thomson Reuters Analyst Awards, second for stock picking in the Health Care Equipment & Supplies sector in the 2008 Thomson Reuters Analyst Awards, and fourth in the medical device sector for stock picking in the 2007 Wall Street Journal Best on the Street. Mike has a BS in Mechanical Engineering from North Carolina State University with a minor in Economics and a MBA from Duke University’s Fuqua School of Business with a concentration in Health Sector Management. Mike holds a medical device patent (U.S. patent 6,919,914).Follow on LinkedIn Mike Matson's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMDTMedtronic6/3/2026Lower Price Target$77.72$101.00Buy$0.0000.00% ROIVCYTVeracyte6/1/2026Boost Price Target$48.79$57.00Buy$0.0000.00% ROIVCYTVeracyte5/28/2026Reiterated Rating$44.49$48.00Buy$0.0000.00% ROIICUIICU Medical5/27/2026Upgrade$134.97$165.00Buy$0.0000.00% ROIBSXBoston Scientific5/18/2026Reiterated Rating$55.35$77.00Buy$0.0000.00% ROIAORTArtivion5/8/2026Lower Price Target$35.38$44.00Buy$0.0000.00% ROITMDXTransMedics Group5/6/2026Lower Price Target$94.93$142.00Buy$0.0000.00% ROISYKStryker5/1/2026Lower Price Target$314.64$418.00Buy$0.0000.00% ROIMMSIMerit Medical Systems5/1/2026Lower Price Target$68.18$90.00Buy$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$64.95$77.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AORTArtivion4/20/2026Reiterated Rating$37.79Buy$0.0000.00% ROIAORTArtivion4/7/2026Reiterated Rating$35.00$58.00Buy$0.0000.00% ROIVCYTVeracyte4/1/2026Reiterated Rating$32.21$48.00Buy$0.0000.00% ROIMMSIMerit Medical Systems4/1/2026Reiterated Rating$68.23$101.00Buy$0.0000.00% ROIBSXBoston Scientific3/30/2026Reiterated Rating$69.21$97.00Buy$0.0000.00% ROIMDTMedtronic3/26/2026Reiterated Rating$87.84$120.00Buy$0.0000.00% ROILUCDLucid Diagnostics3/26/2026Reiterated Rating$1.18$3.00Buy$0.0000.00% ROIBSXBoston Scientific3/20/2026Reiterated Rating$70.04$97.00Buy$0.0000.00% ROIMDTMedtronic3/10/2026Reiterated Rating$90.21$120.00Buy$0.0000.00% ROIKIDSOrthoPediatrics2/27/2026Boost Price Target$17.79$30.00Buy$0.0000.00% ROIPSNLPersonalis2/27/2026Boost Price Target$9.03$12.00Buy$0.0000.00% ROIENOVEnovis2/26/2026Boost Price Target$25.39$52.00Buy$0.0000.00% ROITFXTeleflex2/26/2026Boost Price Target$119.19$147.00Buy$0.0000.00% ROIVCYTVeracyte2/26/2026Boost Price Target$35.72$48.00Buy$0.0000.00% ROIMMSIMerit Medical Systems2/25/2026Lower Price Target$82.43$101.00Buy$0.0000.00% ROITMDXTransMedics Group2/25/2026Boost Price Target$137.78$174.00Buy$0.0000.00% ROILIVNLivaNova2/25/2026Boost Price Target$69.98$81.00Buy$0.0000.00% ROIESTAEstablishment Labs2/24/2026Boost Price Target$76.35$86.00Buy$0.0000.00% ROIMDTMedtronic2/17/2026Lower Price Target$96.33$120.00Buy$0.0000.00% ROINEONeoGenomics2/17/2026Boost Price Target$11.44$15.00Buy$0.0000.00% ROIATRCAtriCure2/12/2026Reiterated Rating$32.90$45.00Buy$0.0000.00% ROIZBHZimmer Biomet2/10/2026Reiterated Rating$92.60Hold$0.0000.00% ROIMDTMedtronic2/9/2026Upgrade$102.89$121.00Buy$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$97.00Buy$0.0000.00% ROIAORTArtivion2/2/2026Reiterated Rating$41.12$58.00Buy$0.0000.00% ROISYKStryker1/30/2026Boost Price Target$354.39$454.00Buy$0.0000.00% ROICNMDCONMED1/29/2026Reiterated Rating$38.59Hold$0.0000.00% ROITFXTeleflex1/27/2026Upgrade$104.13$138.00Buy$0.0000.00% ROIPENPenumbra1/16/2026Downgrade$350.53Hold$0.0000.00% ROIBSXBoston Scientific1/15/2026Reiterated Rating$90.00Buy$0.0000.00% ROIJune 12: $100 Turns Into $100,000? (Ad)The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.Click here to see how to get ahead of the SpaceX IPONEONeoGenomics1/12/2026Reiterated Rating$12.57$14.00Buy$0.0000.00% ROIESTAEstablishment Labs1/12/2026Reiterated Rating$66.13$84.00Buy$0.0000.00% ROIMMSIMerit Medical Systems1/9/2026Reiterated Rating$93.18$108.00Buy$0.0000.00% ROIPENPenumbra12/17/2025Boost Price Target$308.27$388.00Buy$0.0000.00% ROIHAEHaemonetics12/15/2025Downgrade$83.46Hold$0.0000.00% ROIESTAEstablishment Labs12/10/2025Boost Price Target$71.01$84.00Buy$0.0000.00% ROITMDXTransMedics Group12/8/2025Boost Price Target$136.51$166.00Buy$0.0000.00% ROISYKStryker11/14/2025Reiterated Rating$372.93$448.00Buy$0.0000.00% ROILUCDLucid Diagnostics11/13/2025Reiterated Rating$1.11$3.00Buy$0.0000.00% ROIHAEHaemonetics11/7/2025Boost Price Target$67.66$78.00Buy$0.0000.00% ROIAORTArtivion11/7/2025Boost Price Target$47.54$58.00Buy$0.0000.00% ROIESTAEstablishment Labs11/6/2025Boost Price Target$60.51$70.00Buy$0.0000.00% ROIPSNLPersonalis11/5/2025Boost Price Target$8.73$10.00Buy$0.0000.00% ROIVCYTVeracyte11/5/2025Boost Price Target$36.12$44.00Buy$0.0000.00% ROIHOLXHologic11/4/2025Reiterated Rating$74.06Hold$0.0000.00% ROIMMSIMerit Medical Systems10/31/2025Reiterated Rating$83.04$108.00Buy$0.0000.00% ROITMDXTransMedics Group10/30/2025Reiterated Rating$134.32Buy$0.0000.00% ROIKIDSOrthoPediatrics10/29/2025Lower Price Target$16.91$26.00Buy$0.0000.00% ROIPENPenumbra10/27/2025Reiterated Rating$253.61$326.00Buy$0.0000.00% ROITMDXTransMedics Group10/23/2025Upgrade$119.54$148.00Buy$0.0000.00% ROIHOLXHologic10/21/2025Reiterated Rating$74.17Hold$0.0000.00% ROIBSXBoston Scientific10/17/2025Reiterated Rating$98.54$121.00Buy$0.0000.00% ROIINMDInMode10/10/2025Reiterated Rating$15.89Hold$0.0000.00% ROIPENPenumbra10/8/2025Set Price Target$249.05$326.00Buy$0.0000.00% ROIPENPenumbra10/8/2025Upgrade$258.92$326.00Buy$0.0000.00% ROIBSXBoston Scientific10/1/2025Reiterated Rating$97.55$121.00Buy$0.0000.00% ROIBSXBoston Scientific9/19/2025Reiterated Rating$98.29$121.00Buy$0.0000.00% ROIBSXBoston Scientific9/11/2025Reiterated Rating$105.32$121.00Buy$0.0000.00% ROILIVNLivaNova9/3/2025Reiterated Rating$56.92$64.00Buy$0.0000.00% ROINEONeoGenomics8/29/2025Boost Price Target$8.87$14.00Buy$0.0000.00% ROITMDXTransMedics Group8/25/2025Reiterated Rating$117.15Hold$0.0000.00% ROIAORTArtivion8/22/2025Boost Price Target$43.12$50.00Buy$0.0000.00% ROIMDTMedtronic8/14/2025Reiterated Rating$92.04Hold$0.0000.00% ROILUCDLucid Diagnostics8/13/2025Reiterated Rating$0.99$3.00Buy$0.0000.00% ROIAORTArtivion8/8/2025Boost Price Target$32.78$45.00Buy$0.0000.00% ROIENOVEnovis8/7/2025Lower Price Target$28.45$49.00Buy$0.0000.00% ROIHAEHaemonetics8/7/2025Reiterated Rating$56.94$68.00Buy$0.0000.00% ROISYKStryker8/1/2025Boost Price Target$393.37$448.00Buy$0.0000.00% ROIINMDInMode7/30/2025Reiterated Rating$14.09Hold$0.0000.00% ROIATRCAtriCure7/30/2025Boost Price Target$31.73$45.00Buy$0.0000.00% ROINEONeoGenomics7/29/2025Lower Price Target$5.25$8.00Buy$0.0000.00% ROIMMSIMerit Medical Systems7/18/2025Reiterated Rating$84.54$108.00Buy$0.0000.00% ROILUCDLucid Diagnostics7/16/2025Reiterated Rating$1.19$3.00Buy$0.0000.00% ROIMMSIMerit Medical Systems7/8/2025Reiterated Rating$91.12$108.00Buy$0.0000.00% ROITMDXTransMedics Group6/17/2025Reiterated Rating$141.96Hold$0.0000.00% ROICNMDCONMED6/12/2025Downgrade$57.02$61.00Hold$0.0000.00% ROIMDTMedtronic6/6/2025Reiterated Rating$86.92Hold$0.0000.00% ROITMDXTransMedics Group6/3/2025Reiterated Rating$123.94Hold$00.0000.00% ROIINGNInogen5/22/2025Upgrade$5.96$12.00Moderate Buy$0.0000.00% ROIMDTMedtronic5/19/2025Reiterated Rating$86.41Hold$00.0000.00% ROI60 of America’s largest companies are whispering it (Ad)Sixty of the S-and-P 500's largest companies are now using the same word in their legally binding 10-K SEC filings. Pentagon-funded researchers at Rensselaer Polytechnic Institute proved that once 10% of a population adopts an idea, the cascade becomes unstoppable - and 60 out of 500 is 12%. The same threshold fired before cybersecurity became a $200-billion industry, before AWS hit $100 billion a year, and before generative AI appeared in 40% of S-and-P disclosures. Morgan Stanley sizes the next opportunity at $5 trillion. Porter Stansberry has identified the one position he believes sits at the chokepoint.Watch the full documentary to see the word and the position nowMMSIMerit Medical Systems5/15/2025Boost Price Target$97.77$108.00Buy$00.0000.00% ROILUCDLucid Diagnostics5/14/2025Reiterated Rating$1.24$3.00Buy$0.0000.00% ROILIVNLivaNova5/13/2025Reiterated Rating$45.23$64.00Buy$00.0000.00% ROIOCXOncoCyte5/13/2025Reiterated Rating$2.81$4.25Buy$0.0000.00% ROIENOVEnovis5/9/2025Lower Price Target$33.11$57.00Buy$00.0000.00% ROIKIDSOrthoPediatrics5/8/2025Reiterated Rating$22.21$42.00Buy$00.0000.00% ROIVCYTVeracyte5/8/2025Lower Price Target$30.80$41.00Buy$00.0000.00% ROIHAEHaemonetics5/8/2025Lower Price Target$68.55$84.00Buy$00.0000.00% ROIAORTArtivion5/6/2025Reiterated Rating$23.69$32.00Buy$00.0000.00% ROICNMDCONMED5/1/2025Lower Price Target$48.91$61.00Buy$00.0000.00% ROIATRCAtriCure4/30/2025Lower Price Target$34.65$44.00Buy$00.0000.00% ROISRDXSurmodics4/30/2025Reiterated Rating$27.77Hold$0.0000.00% ROINEONeoGenomics4/29/2025Lower Price Target$6.69$8.50Buy$0.0000.00% ROIINMDInMode4/28/2025Reiterated Rating$14.32Hold$00.0000.00% ROIMMSIMerit Medical Systems4/25/2025Lower Price Target$94.67$100.00Buy$00.0000.00% ROIESTAEstablishment Labs4/14/2025Initiated Coverage$30.34Hold$00.0000.00% ROILUCDLucid Diagnostics4/11/2025Reiterated Rating$1.25$3.00Buy$0.0000.00% ROIMASIMasimo4/10/2025Reiterated Rating$164.57Hold$000.0000.00% ROIPSNLPersonalis4/10/2025Reiterated Rating$3.38$7.00Buy$0.0000.00% ROIINGNInogen4/9/2025Reiterated Rating$6.59Hold$0.0000.00% ROIMMSIMerit Medical Systems4/9/2025Reiterated Rating$88.48$116.00Buy$00.0000.00% ROIKIDSOrthoPediatrics4/9/2025Reiterated Rating$21.77$42.00Buy$00.0000.00% ROIENOVEnovis4/9/2025Reiterated Rating$30.60$64.00Buy$00.0000.00% ROIINMDInMode4/9/2025Reiterated Rating$14.48Hold$00.0000.00% ROIICUIICU Medical4/8/2025Reiterated Rating$142.25Hold$000.0000.00% ROIOCXOncoCyte4/8/2025Reiterated Rating$2.84$4.25Buy$0.0000.00% ROISTESTERIS4/7/2025Reiterated Rating$212.69Hold$000.0000.00% ROIENOVEnovis4/2/2025Reiterated Rating$35.88$64.00Buy$00.0000.00% ROIATRCAtriCure3/27/2025Reiterated Rating$33.62$51.00Buy$00.0000.00% ROIOCXOncoCyte3/25/2025Reiterated Rating$3.33$4.25Buy$0.0000.00% ROILUCDLucid Diagnostics3/24/2025Boost Price Target$1.54$3.00Buy$0.0000.00% ROIATRCAtriCure3/21/2025Reiterated Rating$34.82$51.00Buy$00.0000.00% ROISYKStryker3/21/2025Reiterated Rating$373.69$442.00Buy$000.0000.00% ROIHAEHaemonetics3/18/2025Lower Price Target$64.84$104.00Buy$00.0000.00% ROILIVNLivaNova3/17/2025Reiterated Rating$39.24$64.00Buy$00.0000.00% ROITFXTeleflex3/12/2025Reiterated Rating$139.25Hold$000.0000.00% ROIKIDSOrthoPediatrics3/5/2025Reiterated Rating$22.89$42.00Buy$00.0000.00% ROIPSNLPersonalis2/28/2025Lower Price Target$4.24$7.00Buy$0.0000.00% ROIENOVEnovis2/27/2025Lower Price Target$40.03$64.00Buy$00.0000.00% ROIINGNInogen2/26/2025Reiterated Rating$9.52Hold$0.0000.00% ROIMMSIMerit Medical Systems2/26/2025Lower Price Target$102.05$116.00Buy$00.0000.00% ROIMASIMasimo2/26/2025Reiterated Rating$169.54Hold$000.0000.00% ROILIVNLivaNova2/26/2025Lower Price Target$41.70$64.00Buy$00.0000.00% ROIAORTArtivion2/25/2025Lower Price Target$27.90$32.00Buy$00.0000.00% ROIVCYTVeracyte2/25/2025Reiterated Rating$39.36$51.00Buy$00.0000.00% ROIPENPenumbra2/19/2025Reiterated Rating$270.99Hold$000.0000.00% ROIMDTMedtronic2/19/2025Reiterated Rating$86.05Hold$00.0000.00% ROINEONeoGenomics2/19/2025Lower Price Target$12.40$18.00Buy$00.0000.00% ROIATRCAtriCure2/13/2025Reiterated Rating$42.36$51.00Buy$00.0000.00% ROIMDTMedtronic2/12/2025Reiterated Rating$91.18Hold$000.0000.00% ROIRead this warning immediately (Ad)Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.Read Porter Stansberry's full breakdown and protect your wealth nowZBHZimmer Biomet2/7/2025Reiterated Rating$102.84Hold$00.0000.00% ROIHAEHaemonetics2/7/2025Lower Price Target$62.95$108.00Buy$00.0000.00% ROICNMDCONMED2/6/2025Lower Price Target$74.35$91.00Buy$00.0000.00% ROIINMDInMode2/4/2025Reiterated Rating$16.80Hold$00.0000.00% ROIHOLXHologic2/3/2025Downgrade$72.14$90.00Hold$00.0000.00% ROIINGNInogen1/30/2025Reiterated Rating$12.53Hold$0.0000.00% ROISRDXSurmodics1/30/2025Reiterated Rating$35.61Hold$0.0000.00% ROIVCYTVeracyte1/29/2025Boost Price Target$43.67$51.00Buy$00.0000.00% ROISYKStryker1/29/2025Reiterated Rating$394.92$442.00Buy$000.0000.00% ROIMMSIMerit Medical Systems1/29/2025Boost Price Target$109.03$122.00Buy$00.0000.00% ROIZBHZimmer Biomet1/29/2025Reiterated Rating$112.06Hold$00.0000.00% ROIFNAParagon 281/29/2025Reiterated Rating$13.03$13.00Hold$0.0000.00% ROILIVNLivaNova1/28/2025Reiterated Rating$49.53$75.00Buy$00.0000.00% ROIAORTArtivion1/28/2025Reiterated Rating$30.82$34.00Buy$00.0000.00% ROIATRCAtriCure1/22/2025Boost Price Target$39.63$51.00Buy$00.0000.00% ROIMASIMasimo1/22/2025Reiterated Rating$176.07Hold$000.0000.00% ROIMASIMasimo1/16/2025Reiterated Rating$170.69Hold$000.0000.00% ROIKIDSOrthoPediatrics1/14/2025Reiterated Rating$25.00$42.00Buy$00.0000.00% ROIINGNInogen1/14/2025Reiterated Rating$10.33Hold$0.0000.00% ROIMMSIMerit Medical Systems1/14/2025Reiterated Rating$95.64$109.00Buy$00.0000.00% ROIHOLXHologic1/13/2025Reiterated Rating$71.70$90.00Buy$00.0000.00% ROIFNAParagon 281/13/2025Reiterated Rating$10.80$13.00Buy$0.0000.00% ROIATRCAtriCure1/13/2025Reiterated Rating$33.18$40.00Buy$00.0000.00% ROINEONeoGenomics1/10/2025Reiterated Rating$14.93$19.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.